New drug aims to tame rare blood disorder
NCT ID NCT05499013
Summary
This early-stage study is testing an experimental drug called SLN124 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The trial will first find a safe dose, then compare SLN124 against a placebo to see if it can reduce the need for blood removal procedures and control the disease. Researchers will monitor safety, how the drug works in the body, and its effects on blood counts and patient quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research
Nedlands, Australia
-
Research Site
Hammond, Louisiana, 70403, United States
-
Research Site
Buffalo, New York, 14203, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Huntsville, Texas, 77340, United States
-
Research Site
Benowa, Australia
-
Research Site
Hobart, Australia
-
Research Site
Kurralta Park, Australia
-
Research Site
Melbourne, Australia
-
Research Site
Richmond, Australia
-
Research Site
Plovdiv, Bulgaria
-
Research Site
Toronto, Canada
-
Research Site
Freiburg im Breisgau, Germany
-
Research Site
Hanover, Germany
-
Research Site
Alessandria, Italy
-
Research Site
Meldola, Italy
-
Research Site
Johor Bahru, Malaysia
-
Research Site
Kuala Terengganu, Malaysia
-
Research Site
Kuantan, Malaysia
-
Research Site
Kuching, Malaysia
-
Research Site
Gdansk, Poland
-
Research Site
Katowice, Poland
-
Research Site
Lublin, Poland
-
Research Site
Barcelona, Spain
-
Research Site
Madrid, Spain
-
Research Site 2
Melbourne, Australia
-
Research Site 2
Plovdiv, Bulgaria
Conditions
Explore the condition pages connected to this study.